drug commercialization | sciencenewsnet.in

Breaking News

These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

A systematic review of three key sugar metabolism proteins, HXK, SnRK1 and TOR, in the regulatory network of plant growth, development and stress

Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards

Potential new worlds rescued by citizens of Earth! Early results of people-powered astronomy project ‘out of this world’

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

BIMM University chooses Figshare to showcase its non-traditional research and creative practitioner outputs

25 Apr, 2024

Johns Hopkins Drug Commercialization Expert Looks at Controversy over Alzheimer’s Treatment

June 16, 2021 sarah JonasFeature Expert

Johns Hopkins Carey Business School Senior Lecturer Supriya Munshaw – an expert in the commercialization of early-stage technologies, especially in the life science and medical device industries – offers her insights into the FDA’s rationale for approving the Alzheimer’s drug aducanumab, the price set by Biogen, the future of FDA leadership, and other related topics, in this Q&A.

Harrington Discovery Institute Announces New Fund to Advance Breakthrough Discoveries into Novel Treatments

February 18, 2021 sarah JonasAnnouncement

The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute (HDI) at University Hospitals, has collaborated with leading venture investor, Advent Life Sciences (‘Advent’) in the launch of the Advent-Harrington Impact Fund. Advent’s new impact fund, structured alongside Advent Life Sciences Fund III, brings a total of $215 million to advance breakthrough discoveries into novel treatments for the benefit of patients and society.